Latest Articles

Publication Date
Helixor A enhances natural killer cell activity by induction of PAI-1 expression through the p38/MAPK signaling pathway.

Helixor A, an anticancer drug, has an immunostimulatory effect that increases T and natural killer (NK) cell activity in patients with cancer and endometriosis. However, the molecular mechanisms underlying its …

Published: Sept. 12, 2025, midnight
Understanding Endometriosis: A Broad Review of Its Causes, Management, and Impact.

Endometriosis is a complex gynecological condition affecting 10% of women globally, characterized by the growth of endometrial-like tissue outside the uterus, leading to chronic pelvic pain, infertility, reduced quality of …

Published: Sept. 12, 2025, midnight
Efficacy of Elagolix and Relugolix for the Treatment of Pelvic Pain in Patients With Endometriosis: A Systematic Review.

Endometriosis is a chronic gynecological condition commonly associated with pelvic pain, dysmenorrhea, dyspareunia, and infertility. Owing to the limitations and adverse effects of traditional hormonal therapies, this study aimed to …

Published: Sept. 12, 2025, midnight
Neurotrimin, a neural adhesion molecule, expression in early and advanced stage endometriosis.

Endometriosis, a gynecological condition characterized by the presence of endometrial tissue outside the uterus, affects millions of women worldwide. This study aimed to investigate neurotrimin (NTM)'s expression, a glycerophosphatidylinositol-anchored neural …

Published: Sept. 12, 2025, midnight
Professionals Said ENDORISK Is Useful For Risk Estimation of LNM in Endometrial Cancer - Cancer Nursing Today

Professionals Said ENDORISK Is Useful For Risk Estimation of LNM in Endometrial Cancer Cancer Nursing Today

Published: Sept. 11, 2025, 10:50 p.m.
Prognostic Impact of Low-Volume Nodal Metastases in Endometrial Cancer: A Systematic Review of Molecular Subtypes - Frontiers

Prognostic Impact of Low-Volume Nodal Metastases in Endometrial Cancer: A Systematic Review of Molecular Subtypes Frontiers

Published: Sept. 11, 2025, 10:25 p.m.
Fertility clinics could be stopped from using unproven treatment ‘add-ons’ under new guidelines - Stylist

Fertility clinics could be stopped from using unproven treatment ‘add-ons’ under new guidelines Stylist

Published: Sept. 11, 2025, 9:20 p.m.
Montreal ovarian cancer survivor speaks out on gaps of awareness with reproductive cancers - CityNews Montreal

Montreal ovarian cancer survivor speaks out on gaps of awareness with reproductive cancers CityNews Montreal

Published: Sept. 11, 2025, 9:10 p.m.
Q&A with Daniel Powell, President & CEO at Spark Biomedical - citybiz

Q&A with Daniel Powell, President & CEO at Spark Biomedical citybiz

Published: Sept. 11, 2025, 7:23 p.m.
Specialty Type Influences Postcancer HT Prescribing - Medscape

Specialty Type Influences Postcancer HT Prescribing Medscape

Published: Sept. 11, 2025, 1:09 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!